1. Home
  2. MIST

MIST

Milestone Pharmaceuticals Inc.

Logo Milestone Pharmaceuticals Inc.

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

as 04-12-2024 4:00pm EST

$
-
.
-
-
+$
-
.
-
-
+
-
.
-
-
%

Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular indications. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to terminate episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).

Founded: 2003 Country:
Canada
Canada
Employees: N/A City: MONTREAL
Market Cap: 90.1M IPO Year: N/A
Target Price: $11.75 AVG Volume (30 days): 340.3K
Analyst Decision: Buy Number of Analysts: 4
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -1.39 EPS Growth: N/A
52 Week Low/High: $1.33 - $4.49 Next Earning Date: 05-09-2024
Revenue: $1,000,000 Revenue Growth: -80.00%
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

Share on Social Networks: